Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 22 points (-0.1%) at 16,065 as of Monday, Dec. 2, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,030 issues advancing vs. 1,883 declining with 116 unchanged. The Health Services industry currently sits up 0.1% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Parexel International Corporation ( PRXL), down 2.7%, and Grifols ( GRFS), down 0.7%. Top gainers within the industry include DexCom ( DXCM), up 5.3%, Acadia Healthcare Company ( ACHC), up 5.0%, Varian Medical Systems ( VAR), up 1.1% and Humana ( HUM), up 1.0%. TheStreet would like to highlight 5 stocks pushing the industry lower today: 5. Laboratory Corporation of America Holdings ( LH) is one of the companies pushing the Health Services industry lower today. As of noon trading, Laboratory Corporation of America Holdings is down $1.34 (-1.3%) to $100.51 on heavy volume. Thus far, 623,212 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 660,100 shares. The stock has ranged in price between $100.06-$101.61 after having opened the day at $101.46 as compared to the previous trading day's close of $101.85. Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.9 billion and is part of the health care sector. The company has a P/E ratio of 16.8, below the S&P 500 P/E ratio of 17.7. Shares are up 17.6% year to date as of the close of trading on Friday. Currently there are 3 analysts that rate Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, increase in stock price during the past year and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Laboratory Corporation of America Holdings Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.